Check DeSyne X2 coronary stent in a heart registry
Part of Heart & circulation clinical trials.
This study adds people to a registry to track outcomes after getting a specific heart stent called DeSyne X2. It may help doctors understand how well this stent works and how it affects recovery over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 19 years old or older
- Plan to receive the DeSyne X2 drug-eluting coronary stent
- Sign an informed consent form in writing
- Do not receive DeSyne X2 at the same time as another drug-eluting stent
- Have a life expectancy longer than 1 year
- Not be in cardiac shock
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how safe and effective two types of heart stents (Synergy XD and Synergy Megatron) are after they are placed. You might consider it if you’re an adult getting one of these stents and can follow required clinic visits.
This study tests a coronary stent approach for people with significantly blocked heart arteries. It may help by improving blood flow, and it compares treatment in a structured way while monitoring safety and outcomes.
This study follows people who need a coronary (heart) stent to see how they do after treatment. It does not sound like an experimental drug trial for you—it’s mainly about collecting health information after a stent procedure.
This trial tests a new type of stent (a small mesh tube) that slowly releases a medicine called sirolimus to keep your heart artery open after angioplasty. It is designed for people with narrowing in their heart arteries who need a stent.
This trial is checking how well Xience Skypoint stents work and how safe they are for people who need them to open blocked heart arteries. It's for patients getting these stents as part of their normal treatment.
This study follows people who need a heart procedure to open narrowed coronary arteries using a drug-coated stent. It aims to see how well these stents work and how people do in everyday clinical practice.
Hear when a new Coronary Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.